Fingerprint
Dive into the research topics of 'Treatment patterns, glycemic control and bodyweight with canagliflozin 300 mg versus GLP1RAs in Type II diabetes patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Treatment patterns, glycemic control and bodyweight with canagliflozin 300 mg versus GLP1RAs in Type II diabetes patients
Craig I. Coleman, Shivani Pandya, Li Wang, Onur Baser, Jennifer Cai, Mike Ingham, Brahim Bookhart
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations